BioSenic S.A. (BIOS.BR)

EUR 0.0

(0.0%)

Gross Profit Summary of BioSenic S.A.

BioSenic S.A.'s latest annual gross profit in 2023 was 543 Thousand EUR , up 50.0% from previous year.
BioSenic S.A.'s latest quarterly gross profit in 2024 Q2 was 1.24 Million EUR , down 0.0% from previous quarter.
BioSenic S.A. reported a annual gross profit of 206 Thousand EUR in annual gross profit 2022, down -79.13% from previous year.
BioSenic S.A. reported a annual gross profit of 987 Thousand EUR in annual gross profit 2021, down -1.3% from previous year.
BioSenic S.A. reported a quarterly gross profit of 1.34 Million EUR for 2024 Q1, up 3161.36% from previous quarter.
BioSenic S.A. reported a quarterly gross profit of 309 Thousand EUR for 2023 FY, up 50.0% from previous quarter.

Annual Gross Profit Chart of BioSenic S.A. (2023 - 2012)

Historical Annual Gross Profit of BioSenic S.A. (2023 - 2012)

Year	Gross Profit	Gross Profit Growth
2023	543 Thousand EUR	50.0%
2022	206 Thousand EUR	-79.13%
2021	987 Thousand EUR	-1.3%
2020	1 Million EUR	538.6%
2019	-228 Thousand EUR	-122.8%
2018	1 Million EUR	307.9%
2017	-481 Thousand EUR	9.93%
2016	-534 Thousand EUR	-36.22%
2015	-392 Thousand EUR	0.0%
2014	- EUR	0.0%
2013	- EUR	0.0%
2012	- EUR	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	1.24 Million EUR	0.0%
2024 Q1	1.34 Million EUR	3161.36%
2023 FY	309 Thousand EUR	50.0%
2023 Q1	182.5 Thousand EUR	158.87%
2023 Q2	81.5 Thousand EUR	-55.34%
2023 Q3	89 Thousand EUR	9.2%
2023 Q4	-44 Thousand EUR	-149.44%
2022 Q4	70.5 Thousand EUR	0.0%
2022 FY	206 Thousand EUR	-79.13%
2022 Q3	70.5 Thousand EUR	161.84%
2022 Q2	-114 Thousand EUR	0.0%
2021 Q4	930 Thousand EUR	0.0%
2021 FY	987 Thousand EUR	-1.3%
2021 Q2	-64 Thousand EUR	0.0%
2020 Q4	1 Million EUR	0.0%
2020 FY	1 Million EUR	538.6%
2020 Q2	-351 Thousand EUR	0.0%
2019 FY	-228 Thousand EUR	-122.8%
2019 Q2	-389 Thousand EUR	0.0%
2019 Q4	-363 Thousand EUR	0.0%
2018 Q4	1 Million EUR	0.0%
2018 FY	1 Million EUR	307.9%
2017 FY	-481 Thousand EUR	9.93%
2016 FY	-534 Thousand EUR	-36.22%
2015 FY	-392 Thousand EUR	0.0%
2014 Q3	- EUR	0.0%
2014 FY	- EUR	0.0%
2014 Q4	- EUR	0.0%
2013 Q4	- EUR	0.0%
2013 FY	- EUR	0.0%
2012 FY	- EUR	0.0%

Peer Gross Profit Comparison of BioSenic S.A.

Name	Gross Profit	Gross Profit Difference
Nicox S.A.	-11.5 Million EUR	104.721%
European Medical Solutions	13.51 Million EUR	95.981%
FERMENTALG	535 Thousand EUR	-1.495%
argenx SE	925.49 Million EUR	99.941%
Celyad Oncology SA	33 Thousand EUR	-1545.455%
Hyloris Pharmaceuticals SA	1.99 Million EUR	72.768%
Onward Medical N.V.	-14.81 Million EUR	103.664%
Oxurion NV	104 Thousand EUR	-422.115%
PHAXIAM Therapeutics S.A.	1.32 Million EUR	59.05%
Financière de Tubize SA	-2.02 Million EUR	126.754%
UCB SA	3.34 Billion EUR	99.984%